13 October 2017
What is the latest technological and pharmacological news in the cardiological sector? What progress is being made in research on stem cells, myocardial repair, vascular biology and clinical cardiology?
These are some of the themes discussed at the ICCAD, 12th International conference on innovations in coronary artery disease, to be held this year in the magnificent, romantic city of Venice.
Exprivia, an IT company specialized in the healthcare sector providing solutions and services to 500 hospitals with a total of 20 million patients, including cardiological information systems and PACS systems, invites you to the ICCAD conference to find out more about the suite of cardiological solutions.
In particular, Exprivia will present its eCardio solution, the cardiological information system already used in the Cardiology departments of leading hospital institutions, such as Policlinico S. Orsola, Gruppo Villa Maria and Centro Cardiologico Monzino, capable of meeting the requirements of all specialized outpatient, instrumental and ward services through the use of cutting-edge technologies and solutions.
Other themes to be discussed at the ICCAD conference include those of the SMARTool project, financed by the Horizon 2020 programme for European Union research and innovation, of which Exprivia is a partner, whose aim is to develop a cloud platform to provide clinical decisional support for preventing coronary heart disease (CHD) and the main adverse events through fluid dynamic simulation technologies applied to the CT angiographic reconstructions and cardiovascular risk stratification systems.
For further details: www.iccadcongress.com